We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
101
Baidu
BIDU
$35.7B
$838K 0.25%
+3,876
New +$576K
PTH icon
102
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$217M
$833K 0.25%
15,615
+9,414
+152% +$468K
SLB icon
103
SLB Ltd
SLB
$72.7B
$832K 0.24%
38,109
+10,166
+36% +$192K
MDT icon
104
Medtronic
MDT
$112B
$822K 0.24%
7,019
+1,293
+23% +$142K
AWK icon
105
American Water Works
AWK
$27B
$812K 0.24%
5,293
+5,286
+75,514% +$814K
AKAM icon
106
Akamai
AKAM
$15.6B
$790K 0.23%
7,520
-4,919
-40% -$515K
CTXS
107
DELISTED
Citrix Systems Inc
CTXS
$753K 0.22%
5,788
-222
-4% -$28.2K
TDOC icon
108
Teladoc Health
TDOC
$1.66B
$712K 0.21%
3,563
+1,564
+78% +$318K
LLY icon
109
Eli Lilly
LLY
$1.08T
$684K 0.2%
4,050
+2,932
+262% +$438K
XOM icon
110
ExxonMobil
XOM
$650B
$681K 0.2%
16,525
-906
-5% -$34K
HOLX
111
DELISTED
Hologic
HOLX
$677K 0.2%
9,299
+1,447
+18% +$102K
UPS icon
112
United Parcel Service
UPS
$88.9B
$672K 0.2%
3,989
+3,252
+441% +$549K
AQUA
113
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$649K 0.19%
24,067
+19,907
+479% +$494K
MET icon
114
MetLife
MET
$62.4B
$649K 0.19%
13,812
+11,084
+406% +$480K
CCEP icon
115
Coca-Cola Europacific Partners
CCEP
$49.1B
$636K 0.19%
+13,280
New +$561K
BAX icon
116
Baxter International
BAX
$12.8B
$635K 0.19%
7,914
+4,641
+142% +$368K
FXI icon
117
iShares China Large-Cap ETF
FXI
$4.32B
$626K 0.18%
13,493
-940
-7% -$42.9K
BTWN
118
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$619K 0.18%
+40,000
New +$538K
VMW
119
DELISTED
VMware, Inc
VMW
$609K 0.18%
4,339
-93
-2% -$13.3K
CMI icon
120
Cummins
CMI
$83.6B
$608K 0.18%
2,675
+2,396
+859% +$538K
TGTX icon
121
TG Therapeutics
TGTX
$8.19B
$602K 0.18%
11,582
+1,288
+13% +$43.5K
GH icon
122
Guardant Health
GH
$19.1B
$594K 0.17%
4,608
+2,878
+166% +$331K
TSCO icon
123
Tractor Supply
TSCO
$16.3B
$592K 0.17%
21,070
+17,725
+530% +$496K
BG icon
124
Bunge Global
BG
$20.9B
$588K 0.17%
8,968
-13,589
-60% -$793K
TSM icon
125
TSMC
TSM
$1.94T
$572K 0.17%
5,243
+607
+13% +$57.6K

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.